Une traduction en français de ce résumé figure à la fin de l'article. Al final del artículo se facilita una traducción al español. ‫اﻟﺘﺮﺟﻤﺔ‬ ‫اﻟﻌﺮﺑﻴﺔ‬ ‫ﻟەذە‬ ‫اﻟﺨﻼﺻﺔ‬ ‫ﻓﻲ‬ ‫ﻧەاﻳﺔ‬ ‫اﻟﻨﺺ‬ ‫اﻟﻜﺎﻣﻞ‬ ‫ﻟەذە‬ ‫.اﻟﻤﻘﺎﻟﺔ‬
Introduction
Lack of health insurance can deprive the poor of access to services or put them at risk of financial hardship. To protect the poor against excessive health expenditures, many countries have implemented mechanisms such as community-based health insurance, 1, 2 national health insurance [3] [4] [5] [6] and targeted public health insurance. 7, 8 Mexico has multiple health insurance providers. covers for private-sector employees. By 2001, however, nearly half of the Mexican working-age population had no health insurance. 9 The Seguro Popular [People's Insurance], launched that year, represented a major effort to protect the working-age population against steep health-care costs. Enrolment in the Seguro Popular is not dependent on health status or pre-existing illness, there is no co-payment in accordance with the type of health care received, and family contributions are determined solely by ability to pay. 10 Medical interventions are offered mainly through the public health network.
The Seguro Popular, which covers health care for many diseases, including cancer, asthma, anaemia, pneumonia and diabetes, 11 was implemented gradually between 2001 and 2005, but only in communities with health units having accreditation, that is, the proven capacity -medical resources, personnel and infrastructure, etc. -to provide the health interventions covered by the Seguro Popular. Thus, during the implementation phase, people chose to enrol based largely on programme availability at the regional level, and this, in turn, was determined by health infrastructure capacity.
Background
According to WHO estimates, by 2030, approximately 366 million adults will have diabetes (type 2 in over 90% of the cases), and 75% of these adults will be living in developing countries. 12 We selected a subsample of 2960 adults with diabetes (i.e. adults who had been diagnosed with diabetes by a physician or who reported being under treatment for diabetes). After we excluded pregnant women with hyperglycaemia (assumed to have gestational diabetes), adults with access to social security services, and responses with missing data, our final sample for analysis included 1491 adults.
Adults (aged 20-80 years) provided the following information: number of visits to physicians for diabetes control; frequency and type of treatment (diet, alternative medicines or standard drug therapy, such as insulin and oral hypoglycaemic agents);
and access to laboratory tests, including testing frequency. In addition, a random subsample of patients (n = 1115) was selected for HbA1c testing.
Variables
We analysed access outcomes and biological outcomes. The first included access to laboratory tests; four or more yearly visits to a physician for diabetes control; treatment with any drug, including insulin; number of weekly insulin injections (if on insulin);
and number of blood glucose control tests per month. and were then further classified in accordance with the more extreme values: "very poor glucose control" (HbA1c > 12%) or "appropriate and poor glucose control" (HbA1c ≤ 12%). Patients in the "very poor glucose control" category were those having the poorest outcomes and the highest risk of premature death and complications. 23 For analysis, health insurance status, as reported by surveyed individuals, was the exposure variable. We compared individuals enrolled in the Seguro Popular ("treatment" category) with individuals who reported having no insurance (control category).
We assessed characteristics of the individual, the household and the state as treatment predictors: for the individual, age, sex, education and ethnicity; for the household, family assets (as a proxy for family wealth) and rural or urban residential area; for the state, the general region of the country (north, east central, west central and south-southeast). We also considered potential confounders (e.g. using body mass index as a proxy for lifestyle) and time since diabetes was diagnosed.
Finally, data from Mexico's 2005 Registro Nacional de Infraestructura en Salud
[National Registry of Health Infrastructure] to determine whether the availability of health professionals (i.e. the numbers of physicians and nurses) and health units per 1000 population modified the treatment effect. 24 To estimate the number of physicians, nurses and health units per 1000 population, we used 2005 census data for municipalities generated by Mexico's National Geographical Institute.
25

Statistical methods
Because enrolment in the Seguro Popular is voluntary, health insurance status is not randomly allocated and the data may be subject to self-selection bias. To reduce this bias, we used standard propensity score matching. We first constructed a propensity score that estimated the probability of enrolment in the Seguro Popular given a set of predictors, and we then created a control group (uninsured) and a treatment group (insured) having similar propensity scores. We used a logistic regression model to estimate the conditional probability of Seguro Popular enrolment, given a set of covariates (X). Nearest neighbour matching allowed us to match insured and uninsured individuals with similar propensity scores. 26, 27 If outcomes are assumed to be independent of programme participation after controlling for propensity score, the average treatment effect is:
where To ensure comparability, we tested the balancing property: pre-treatment covariates did not differ statistically between Seguro Popular enrollees and people without health insurance. 28 We followed the algorithm suggested by Dehejia and We performed sensitivity analysis to test the association of HbA1c results with the potential lifestyle confounders (using BMI as a proxy for lifestyle) and the time since diabetes was first diagnosed. We also checked the independent effect of Seguro Popular enrolment and of health professional availability on the coverage of diabetes treatment and control. This involved estimating a multivariate model using matched data for two outcomes: regular use of any blood glucose control test and proportion of patients with "very poor glucose control". We adjusted the multivariate model with clustering for the potential effect modifier of health professional availability, as determined by the number of physicians, nurses and health units in a given location compared with the median for the entire municipality. showed statistical significance for the entire sample; however, for the propensity score estimation, the t test showed statistically insignificant differences for the covariables at each of the seven propensity score blocks (results not shown). Table 2 shows the logistic regression model for propensity scores. In the model, females and married people were more likely to be enrolled in the Seguro Popular, as were adults with diabetes who had fewer assets or who lived in rural areas or in the west central region. We then analysed the interaction between the number of physicians, nurses and health units per 1000 population and the "very poor glucose control" indicator. Sensitivity analyses showed that the association between potential confounders (BMI as proxy for lifestyle and time since diabetes first diagnosed) and health-care outcomes was not significant. Such confounders were significantly associated with the biological outcomes but did not substantially modify the results presented already. The additional covariates showed no significance in the propensity score model.
Results
Discussion
The findings of this study suggest that the Seguro Popular has improved both access to health services and biological health outcomes among adults with diabetes. Over the past 20 years, various countries in Latin America -Argentina, Brazil, Chile and Colombia -have implemented health insurance reform to improve the coverage of marginalized groups. 32 The current study demonstrates the success of an insurance programme targeted to the poor in Mexico. Its results may be relevant for other Publication: Bulletin of the World Health Organization; Type: Research Article DOI: 10.2471/BLT.08.053256
Page 9 of 17 populations living in a similar socio-economic setting and may help to shape programmes for improving access to health services and health status among the poor.
Although adults with diabetes who were Seguro Popular enrollees had better access to health care and better blood glucose level control, the effect of enrolment on biological outcomes was modest: a large proportion of both the insured and uninsured remained in the "very poor glucose control" category. It is too early to determine whether the Seguro Popular will reduce premature deaths from the chronic complications of diabetes, but continued emphasis on quality of care and treatment will be necessary to meet this long-term goal.
Limitations
This study has limitations. It is cross-sectional, hence it captures only a single point in time.
Responses to questions about the past are subject to recall bias. Furthermore, selfreported outcomes, such as the number of visits to a physician, are subject to reporting bias. The biological tests performed provide more objective measures. Although we controlled for many variables that influence insurance choice (including age, sex, marital status and residential region), other factors (e.g. genetic or environmental) could also make an individual more prone to diabetes and less likely to enrol in the Seguro Popular. We also assumed (as is common in studies with propensity score matching)
that unobservable components could be ignored.
Health insurance for the poor is a relatively new concept and its effect has not been widely evaluated yet. The results provided here are among the very few based on an assessment of individual health status indicators. As the the Seguro Popular programme is quite new, these are early results; effects over the longer term should be the subject of future research. 
